Ference et al. showed that the CHD risk associated with variation in genes known to affect TG and, by extrapolation, triglyceride-rich lipoproteins (TRL) was similar to the risk associated with variation in genes affecting LDL for the same variation in apoB particle number. The gene discussed is APOB; the disease is coronary artery disorder.